Clearwater Paper Reports Second Quarter 2013 Results

Clearwater Paper Reports Second Quarter 2013 Results

SPOKANE, Wash.--(BUSINESS WIRE)-- Clearwater Paper Corporation (NYSE: CLW) today reported financial results for the second quarter of 2013.

The company reported net sales of $471.0 million for the second quarter of 2013, compared to net sales of $473.6 million for the second quarter of 2012. Net earnings for the second quarter of 2013 were $11.7 million, or $0.52 per diluted share, compared to net earnings of $21.5 million, or $0.91 per diluted share, for the second quarter of 2012. Net earnings for the 2013 period included a $1.1 million benefit associated with the mark-to-market impact of directors' equity-based compensation and $1.0 million of expense associated with the announced closing of the company's Thomaston, Ga., converting and distribution facility. Excluding those items, second quarter 2013 net earnings were $11.6 million, or $0.51 per diluted share. For the second quarter of 2012, excluding $1.0 million of expenses associated with the Metso litigation, a $1.0 million loss associated with the sale of legacy Cellu Tissue foam manufacturing assets and $0.3 million of expense associated with the mark-to-market impact of directors' equity-based compensation, net earnings were $23.0 million, or $0.97 per diluted share.

Earnings before interest, taxes, depreciation and amortization, or EBITDA, was $53.0 million for the second quarter of 2013. Adjusted EBITDA of $52.8 million was down 20.6% compared to second quarter 2012 Adjusted EBITDA of $66.5 million. The decrease in EBITDA and Adjusted EBITDA was due to higher transportation and purchased paper costs in the Consumer Products segment as a result of the through-air-dried (TAD) transition, as well as overall higher energy, wages and benefits, and maintenance costs.

"Our focus on internal execution in tissue and strong fundamentals in paperboard drove the quarter's solid progress in EBITDA. Our new TAD tissue facility in Shelby, N.C., continues to ramp up consistent with our expectations," said Linda Massman, president and chief executive officer. "As a result, we continue to anticipate achieving our $300 million adjusted EBITDA target in 2014."

During the second quarter, the company repurchased approximately 205,000 shares of common stock at a total cost of $9.8 million pursuant to its previously announced $100 million share buyback program. Since announcing the program in January, the company has repurchased approximately 1.0 million shares. The company expects to use the balance of its overall $100 million share repurchase program by the end of 2013.


Consumer Products

Net sales in the Consumer Products segment were $289.7 million for the second quarter of 2013, up 2.3% compared to second quarter 2012 net sales of $283.1 million. The increase was primarily attributable to higher selling prices, with volumes flat year over year. Operating income decreased to $14.8 million from $25.7 million in the prior year period, driven primarily by short-term transition costs of $4.2 million associated with the company's TAD expansion. Operating income was also adversely impacted by expenses related to the announced closure of the company's Thomaston facility, higher energy and packaging costs, and increased depreciation year over year.

  • Tissue sales volumes of 132,057 tons in the second quarter of 2013 were roughly flat compared to the second quarter of 2012. Retail tons and converted product cases shipped increased 3.5% and 3.8%, respectively, with non-retail tons dropping 5.7% during the second quarter of 2013.
  • Average net selling prices increased 3.1% to $2,194 per ton in the second quarter of 2013 compared to the second quarter of 2012, due to increased TAD sales, improved mix, and parent roll and away-from-home price increases during the second quarter of 2013.
  • TAD transition costs included increased transportation, manufacturing and outside purchased paper costs associated with the increased conventional tissue sales the company took on to help offset the displacement of conventional sales expected by the ramp up of the company's new Ultra TAD bathroom tissue product in 2013.

Pulp and Paperboard

Net sales in the Pulp and Paperboard segment were $181.3 million for the second quarter of 2013, down 4.8% compared to second quarter 2012 net sales of $190.5 million. The decrease was primarily due to lower paperboard volumes driven by short-term production issues and lower pricing in the second quarter of 2013 compared to the second quarter of 2012. Operating income for the quarter decreased $7.2 million to $24.8 million, compared to $32.0 million for the second quarter of 2012, primarily due to higher energy and employee costs as well as operational disruptions at the company's Arkansas facility in the second quarter of 2013.

  • Paperboard sales volumes decreased 1.4% to 190,518 tons in the second quarter of 2013, compared to the second quarter of 2012.
  • Paperboard net selling prices decreased 3.0% to $946 per ton compared to the second quarter of 2012 as a result of competitive pressures across most product segments.
  • An electrical disruption and operational issues with maintenance and repairs performed on the recovery boiler in Arkansas in the second quarter of 2013 resulted in increased costs of approximately $2.9 million during the quarter.


The company's effective tax rate for the second quarter of 2013 was a provision of 37.4%, compared to a provision of 39.2% in the second quarter of 2012. The lower effective rate was primarily the result of a return to provision true up partially offset by interest accrued on uncertain tax positions in the reporting period. The company expects its annual effective tax rate to be approximately 38% for 2013.

Note Regarding Use of Non-GAAP Financial Measures

In this press release, the company presents its results for the second quarters of 2013 and 2012, including EBITDA, Adjusted EBITDA, adjusted net earnings and adjusted net earnings per diluted share excluding special items. These amounts are not in accordance with generally accepted accounting principles (GAAP), and accordingly reconciliations to net earnings and net earnings per diluted share as determined in accordance with GAAP are included at the end of this press release. The company presents these amounts because management believes they assist investors and analysts in comparing the company's performance across reporting periods on a consistent basis by excluding items that the company does not believe are indicative of its core operating performance.


A live audio webcast and conference call will be held today, Wednesday, July 24, 2013, at 2 p.m. Pacific time (5 p.m. Eastern time). Investors may access the conference call by dialing 877-303-9241 (for U.S./Canada investors) or 760-666-3575 (for international investors). The audio webcast may be accessed on the company's website at An accompanying presentation including supplemental information will be available for downloading at the same site at 1:05 p.m. Pacific time (4:05 p.m. Eastern time). The webcast will be audio only. The company recommends that investors download the accompanying presentation prior to the call.

For those unable to participate in the call, an archived recording will be available through the Clearwater Paper Corporation website at under "Investor Relations" following the conference call.


Clearwater Paper manufactures quality consumer tissue, away-from-home tissue, parent roll tissue, machine-glazed tissue, bleached paperboard and pulp at 15 manufacturing locations in the U.S. and Canada. The company is a premier supplier of private label tissue to major retailers and wholesale distributors. This includes grocery, drug, mass merchants and discount stores. The company also produces bleached paperboard used by quality-conscious printers and packaging converters. Clearwater Paper's employees build shareholder value by developing strong customer relationships through quality and service.


This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as amended, including the company's expected production at its North Carolina facility, sales of TAD tissue, Adjusted EBITDA target for 2014, the expected completion of the company's $100 million common stock repurchase program, and the company's effective tax rates for 2013. These forward-looking statements are based on current expectations, estimates, assumptions and projections that are subject to change, and actual results may differ materially from the forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, customer acceptance and timing of purchases of the company's new TAD products and capacity, difficulties with the optimization and realization of the benefits expected from the company's new TAD paper machine and converting lines at North Carolina; changes in the cost and availability of wood fiber and wood pulp; manufacturing or operating disruptions, including equipment malfunction and damage to the company's manufacturing facilities; changes in transportation costs and disruptions in transportation services; changes in costs for and availability of packaging supplies, chemicals, energy, and maintenance and repairs; competitive pricing pressures for the company's products, including as a result of increased capacity as additional manufacturing facilities are operated by the company's competitors; changes in customer product preferences and competitors' product offerings; increased supply and pricing pressures resulting from increasing Asian paper production capabilities; changes in the U.S. and international economies and in general economic conditions in the regions and industries in which the company operates; cyclical industry conditions; reliance on a limited number of third-party suppliers for raw materials; labor disruptions; inability to successfully implement the company's expansion strategies; limitations on stock repurchases pursuant to Rule 10b-18 under the Securities Exchange Act of 1934; the company's qualification to retain, or ability to utilize, tax credits associated with alternative fuels or cellulosic biofuels and the tax treatment associated with receipt of such credits; and other risks and uncertainties described from time to time in the company's public filings with the Securities and Exchange Commission. The forward-looking statements are made as of the date of this press release and the company does not undertake to update any forward-looking statements.

For additional information on Clearwater Paper, please visit the company's website

Clearwater Paper Corporation
Condensed Consolidated Statements of Operations
Unaudited (Dollars in thousands - except per-share amounts)
Three Months Ended


Six Months Ended

June 30,June 30,
   2013     2012    2013     2012   
Net sales $471,002  100% $473,572  100%$931,826  100% $931,370  100%
Costs and expenses:
Cost of sales(414,521)88%(398,546)84%(828,730)89%(801,622)86%
Selling, general and administrative expenses  (26,767) 6%  (30,529) 6% (60,899) 7%  (59,603) 6%
Total operating costs and expenses  (441,288) 94%  (429,075) 91% (889,629) 95%  (861,225) 92%
Income from operations29,7146%44,4979%42,1975%70,1458%
Interest expense, net(11,094)2%(9,147)2%(22,076)2%(18,875)2%
Debt retirement costs  -  -   -  -  (17,058) 2%  -  - 
Earnings before income taxes18,6204%35,3507%3,063-51,2706%
Income tax (provision) benefit  (6,962) 1%  (13,861) 3% 7,713  1%  (26,055) 3%
Net earnings $11,658  2% $21,489  5%$10,776  1% $25,215  3%
Net earnings per common share:
Average shares outstanding (in thousands):

Clearwater Paper Corporation
Condensed Consolidated Balance Sheets
Unaudited (Dollars in thousands)
June 30,December 31,
  2013 2012
Current assets:
Restricted cash1,500-
Short-term investments80,00020,000
Receivables, net169,397154,143
Taxes receivable8,91020,828
Deferred tax assets23,97617,136
Prepaid expenses  10,159   12,314 
Total current assets546,456468,466
Property, plant and equipment, net868,365877,377
Intangible assets, net44,15647,753
Other assets, net  10,398   10,327 
TOTAL ASSETS $1,698,908  $1,633,456 
Current liabilities:
Accounts payable and accrued liabilities$158,390$165,596
Current liability for pensions and other postretirement employee benefits  9,137   9,137 
Total current liabilities167,527174,733
Long-term debt650,000523,933
Liability for pensions and other postretirement employee benefits196,581204,163
Other long-term obligations50,43750,910
Accrued taxes75,93678,699
Deferred tax liabilities60,77460,124
Stockholders' equity, excluding accumulated other comprehensive loss, net of tax608,434656,587
Accumulated other comprehensive loss, net of tax  (110,781)  (115,693)

Read Full Story
Scroll to continue with content AD
  • DJI25886.01306.611.20%
    S&P 5002888.6841.081.44%
  • NIKKEI 22520418.8113.110.06%
    Hang Seng25734.22238.760.94%
  • USD (PER EUR)1.110.00000.00%
    USD (PER CHF)1.020.00000.00%
    JPY (PER USD)106.360.00000.00%
    GBP (PER USD)1.210.00000.00%
More to Explore
Clearwater Paper Corporation
Condensed Consolidated Statements of Cash Flows
Unaudited (Dollars in thousands)
Six Months Ended

June 30,

  2013 2012
Net earnings$10,776$25,215
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization45,40439,278
Deferred tax (benefit) provision(9,384)12,780
Equity-based compensation expense5,5813,631
Employee benefit plans5,0984,040
Deferred issuance costs and discounts on long-term debt4,0171,121
Disposal of plant and equipment, net-1,501
Changes in working capital, net(43,805)22,621
Changes in taxes receivable, net11,918(3,813)
Excess tax benefits from equity-based payment arrangements-(5,793)
Changes in non-current accrued taxes, net(2,763)3,526
Funding of qualified pension plans(4,633)(15,525)
Other, net